Ghulam J. Mufti

18.9k total citations · 2 hit papers
268 papers, 11.2k citations indexed

About

Ghulam J. Mufti is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Ghulam J. Mufti has authored 268 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 198 papers in Hematology, 86 papers in Genetics and 80 papers in Molecular Biology. Recurrent topics in Ghulam J. Mufti's work include Acute Myeloid Leukemia Research (147 papers), Hematopoietic Stem Cell Transplantation (66 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (47 papers). Ghulam J. Mufti is often cited by papers focused on Acute Myeloid Leukemia Research (147 papers), Hematopoietic Stem Cell Transplantation (66 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (47 papers). Ghulam J. Mufti collaborates with scholars based in United Kingdom, United States and France. Ghulam J. Mufti's co-authors include Alan F. List, Pierre Fenaux, Antonio Pagliuca, Lewis R. Silverman, Eva Hellström‐Lindberg, Austin Kulasekararaj, Valeria Santini, Steven D. Gore, John F. Seymour and Norbert Gattermann and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nucleic Acids Research.

In The Last Decade

Ghulam J. Mufti

260 papers receiving 11.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

2009 1.8k citations Pierre Fenaux, Ghulam J. Mufti et al. profile →
Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia

2009 698 citations Pierre Fenaux, Ghulam J. Mufti et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ghulam J. Mufti United Kingdom	55	7.7k	4.0k	2.9k	2.2k	1.8k	268	11.2k
Azra Raza United States	50	8.8k 1.2×	5.5k 1.4×	3.6k 1.2×	1.3k 0.6×	1.6k 0.9×	278	12.3k
Gert J. Ossenkoppele Netherlands	53	8.6k 1.1×	4.4k 1.1×	2.8k 0.9×	1.9k 0.9×	2.8k 1.6×	279	12.3k
Eva Hellström‐Lindberg Sweden	40	8.2k 1.1×	4.0k 1.0×	3.8k 1.3×	960 0.4×	1.2k 0.7×	187	10.6k
Christian Thiede Germany	56	6.7k 0.9×	3.7k 0.9×	2.7k 0.9×	1.6k 0.8×	2.2k 1.2×	268	12.1k
Peter L. Greenberg United States	45	9.1k 1.2×	3.2k 0.8×	3.8k 1.3×	1.0k 0.5×	1.7k 1.0×	203	11.0k
Donna E. Hogge Canada	54	5.5k 0.7×	3.5k 0.9×	1.8k 0.6×	2.2k 1.0×	2.5k 1.4×	251	9.5k
Nigel H. Russell United Kingdom	57	8.9k 1.2×	4.4k 1.1×	2.5k 0.9×	1.9k 0.9×	3.3k 1.9×	355	12.4k
David F. Claxton United States	40	5.6k 0.7×	2.8k 0.7×	1.5k 0.5×	2.6k 1.2×	2.6k 1.5×	195	9.1k
Aristoteles Giagounidis Germany	49	8.5k 1.1×	3.4k 0.8×	3.7k 1.3×	692 0.3×	1.2k 0.7×	259	10.3k
Tessa L. Holyoake United Kingdom	59	7.5k 1.0×	3.8k 0.9×	4.7k 1.6×	1.2k 0.6×	2.2k 1.2×	219	11.1k

Countries citing papers authored by Ghulam J. Mufti

Since Specialization

Citations

This map shows the geographic impact of Ghulam J. Mufti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ghulam J. Mufti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ghulam J. Mufti more than expected).

Fields of papers citing papers by Ghulam J. Mufti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ghulam J. Mufti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ghulam J. Mufti. The network helps show where Ghulam J. Mufti may publish in the future.

Co-authorship network of co-authors of Ghulam J. Mufti

This figure shows the co-authorship network connecting the top 25 collaborators of Ghulam J. Mufti. A scholar is included among the top collaborators of Ghulam J. Mufti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ghulam J. Mufti. Ghulam J. Mufti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Costantini, Benedetta, Syed A. Mian, Pilar Perez Abellan, et al.. (2020). Treg sensitivity to FasL and relative IL-2 deprivation drive idiopathic aplastic anemia immune dysfunction. Blood. 136(7). 885–897. 21 indexed citations

Mian, Syed A., Ander Abarrategi, Kar Lok Kong, et al.. (2020). Ectopic Humanized Mesenchymal Niche in Mice Enables Robust Engraftment of Myelodysplastic Stem Cells. Blood Cancer Discovery. 2(2). 135–145. 21 indexed citations

Gaymes, Terry J., et al.. (2017). FLT3 and JAK2 Mutations in Acute Myeloid Leukemia Promote Interchromosomal Homologous Recombination and the Potential for Copy Neutral Loss of Heterozygosity. Cancer Research. 77(7). 1697–1708. 22 indexed citations

Keohane, Clodagh, Shahram Kordasti, Thomas Seidl, et al.. (2015). JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells. British Journal of Haematology. 171(1). 60–73. 68 indexed citations

Mian, Syed A., Kevin Rouault‐Pierre, Alexander Smith, et al.. (2015). SF3B1 mutant MDS-initiating cells may arise from the haematopoietic stem cell compartment. Nature Communications. 6(1). 10004–10004. 64 indexed citations

Kulasekararaj, Austin, Jie Jiang, Alexander Smith, et al.. (2014). Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome. Blood. 124(17). 2698–2704. 168 indexed citations

Jädersten, Martin, Leonie Saft, Alexander Smith, et al.. (2011). TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression. Journal of Clinical Oncology. 29(15). 1971–1979. 332 indexed citations

Marsh, Judith, Vikas Gupta, ZiYi Lim, et al.. (2011). Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia. Blood. 118(8). 2351–2357. 105 indexed citations

Craythorne, Emma, et al.. (2011). Rituximab for the treatment of corticosteroid - refractory pemphigus vulgaris with oral and skin manifestations. Journal of Oral Pathology and Medicine. 40(8). 616–620. 21 indexed citations

10.

Buggins, Andrea G.S., Chris Pepper, Piers Patten, et al.. (2010). Interaction with Vascular Endothelium Enhances Survival in Primary Chronic Lymphocytic Leukemia Cells via NF-κB Activation and De novo Gene Transcription. Cancer Research. 70(19). 7523–7533. 75 indexed citations

11.

Matthews, Katie, ZiYi Lim, Laurence Pearce, et al.. (2010). Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab. British Journal of Haematology. 149(6). 879–889. 9 indexed citations

12.

Fenaux, Pierre, Ghulam J. Mufti, Eva Hellström‐Lindberg, et al.. (2009). Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia. Journal of Clinical Oncology. 28(4). 562–569. 698 indexed citations breakdown →

13.

Szende, Ágota, Caroline Schaefer, Thomas F. Goss, et al.. (2009). Valuation of transfusion-free living in MDS: results of health utility interviews with patients. Health and Quality of Life Outcomes. 7(1). 81–81. 42 indexed citations

14.

Rassool, Feyruz V., Terry J. Gaymes, Nader Omidvar, et al.. (2007). Reactive Oxygen Species, DNA Damage, and Error-Prone Repair: A Model for Genomic Instability with Progression in Myeloid Leukemia?. Cancer Research. 67(18). 8762–8771. 130 indexed citations

15.

Gaymes, Terry J., Rose Ann Padua, Marika Pla, et al.. (2006). Histone Deacetylase Inhibitors (HDI) Cause DNA Damage in Leukemia Cells: A Mechanism for Leukemia-Specific HDI-Dependent Apoptosis?. Molecular Cancer Research. 4(8). 563–573. 77 indexed citations

16.

Lim, ZiYi, Antonio Pagliuca, Simon Cottam, et al.. (2006). Outcomes of patients with haematological malignancies admitted to intensive care unit. A comparative review of allogeneic haematopoietic stem cell transplantation data. British Journal of Haematology. 136(3). 448–450. 21 indexed citations

17.

Westwood, Nigel & Ghulam J. Mufti. (2003). Apoptosis in the myelodysplastic syndromes.. PubMed. 2(3). 186–92. 11 indexed citations

18.

Parker, Jane E., Tariq Shafi, Antonio Pagliuca, et al.. (2002). Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced‐intensity conditioning compared with standard preparative regimens. British Journal of Haematology. 119(1). 144–154. 66 indexed citations

19.

Gaymes, Terry J., Phillip North, Nicola Brady, et al.. (2002). Increased error-prone non homologous DNA end-joining – a proposed mechanism of chromosomal instability in Bloom's syndrome. Oncogene. 21(16). 2525–2533. 85 indexed citations

20.

Buggins, Andrea G.S., Dragana Milojković, Matthew Arno, et al.. (2001). Microenvironment Produced by Acute Myeloid Leukemia Cells Prevents T Cell Activation and Proliferation by Inhibition of NF-κB, c-Myc, and pRb Pathways. The Journal of Immunology. 167(10). 6021–6030. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact